Ampio Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2018 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Ampio Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2018 to Q4 2023.
  • Ampio Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2023 was 810K shares, a 7.5% increase year-over-year.
  • Ampio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 810K shares, a 7.5% increase from 2022.
  • Ampio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 754K shares, a 94.5% decline from 2021.
  • Ampio Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 13.7M shares, a 92.1% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 810K +56.5K +7.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 804K +50.5K +6.71% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 15.1M +21.6K +0.14% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 15.1M +19.8K +0.13% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-08
Q4 2022 754K -12.9M -94.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 754K -12.7M -94.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 15.1M -186M -92.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 15.1M -186M -92.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 13.7M -159M -92.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 13.4M -165M -92.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 201M +35.1M +21.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 201M +40.2M +25% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 173M +41.7M +31.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 179M +36.4M +25.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 166M +47.6M +40.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 161M +49.5M +44.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 131M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 142M +26.9M +23.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-03
Q2 2019 119M +25.8M +27.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 111M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q3 2018 115M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 93M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.